178 related articles for article (PubMed ID: 17306361)
21. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
Folkman J
Exp Cell Res; 2006 Mar; 312(5):594-607. PubMed ID: 16376330
[TBL] [Abstract][Full Text] [Related]
22. Progress in antiangiogenic gene therapy of cancer.
Feldman AL; Libutti SK
Cancer; 2000 Sep; 89(6):1181-94. PubMed ID: 11002212
[TBL] [Abstract][Full Text] [Related]
23. Endogenous inhibitors of angiogenesis.
Nyberg P; Xie L; Kalluri R
Cancer Res; 2005 May; 65(10):3967-79. PubMed ID: 15899784
[TBL] [Abstract][Full Text] [Related]
24. Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer.
Langenkamp E; Molema G
Cell Tissue Res; 2009 Jan; 335(1):205-22. PubMed ID: 18677515
[TBL] [Abstract][Full Text] [Related]
25. Interferon-mediated anti-angiogenic therapy for neuroblastoma.
Streck CJ; Ng CY; Zhang Y; Zhou J; Nathwani AC; Davidoff AM
Cancer Lett; 2005 Oct; 228(1-2):163-70. PubMed ID: 15927362
[TBL] [Abstract][Full Text] [Related]
26. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms regulating the angiogenic phenotype in tumors: clinical impact in the future.
Aubry K; Barriere G; Chable-Rabinovitch H; Dutour A; Paraf F; Monteil J; Rigaud M
Anticancer Res; 2007; 27(5A):3111-9. PubMed ID: 17970051
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.
Almog N; Ma L; Raychowdhury R; Schwager C; Erber R; Short S; Hlatky L; Vajkoczy P; Huber PE; Folkman J; Abdollahi A
Cancer Res; 2009 Feb; 69(3):836-44. PubMed ID: 19176381
[TBL] [Abstract][Full Text] [Related]
29. Ischemic vascular disease and solid cancers: opposing ends of the angiogenic spectrum?
Balasubramanian SP; Reed MW
Med Hypotheses; 2006; 67(6):1317-9. PubMed ID: 16828237
[TBL] [Abstract][Full Text] [Related]
30. Lethality in an anti-angiogenic tumor gene therapy model upon constitutive but not inducible expression of the soluble vascular endothelial growth factor receptor 1.
Sivanandam VG; Stephen SL; Hernandez-Alcoceba R; Alzuguren P; Zabala M; van Rooijen N; Qian C; Berger I; Gross ML; Prieto J; Kochanek S
J Gene Med; 2008 Oct; 10(10):1083-91. PubMed ID: 18720430
[TBL] [Abstract][Full Text] [Related]
31. Angioarrestin: a unique angiopoietin-related protein with anti-angiogenic properties.
Dhanabal M; Jeffers M; LaRochelle WJ; Lichenstein HS
Biochem Biophys Res Commun; 2005 Jul; 333(2):308-15. PubMed ID: 15950186
[TBL] [Abstract][Full Text] [Related]
32. [Tumor angiogenesis].
Bikfalvi A
Bull Cancer; 2007; 94(7 Suppl):F193-8. PubMed ID: 17964996
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.
Dell'Eva R; Pfeffer U; Indraccolo S; Albini A; Noonan D
Endothelium; 2002; 9(1):3-10. PubMed ID: 12901356
[TBL] [Abstract][Full Text] [Related]
34. Angiogenesis as an immunopharmacologic target in inflammation and cancer.
Bian XW; Chen JH; Jiang XF; Bai JS; Wang QL; Zhang X
Int Immunopharmacol; 2004 Nov; 4(12):1537-47. PubMed ID: 15351323
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
Cao Y
Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
[TBL] [Abstract][Full Text] [Related]
36. Discovery and development of anti-angiogenic peptides: A structural link.
Dings RP; Nesmelova I; Griffioen AW; Mayo KH
Angiogenesis; 2003; 6(2):83-91. PubMed ID: 14739615
[TBL] [Abstract][Full Text] [Related]
37. Managing tumor angiogenesis: lessons from VEGF-resistant tumors and wounds.
Cuevas I; Boudreau N
Adv Cancer Res; 2009; 103():25-42. PubMed ID: 19854351
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for the functions of endogenous angiogenesis inhibitors.
Grant MA; Kalluri R
Cold Spring Harb Symp Quant Biol; 2005; 70():399-410. PubMed ID: 16869777
[TBL] [Abstract][Full Text] [Related]
39. Angiogenesis and vascular targeting: relevance for hyperthermia.
Horsman MR
Int J Hyperthermia; 2008 Feb; 24(1):57-65. PubMed ID: 18214769
[TBL] [Abstract][Full Text] [Related]
40. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
Shibuya M
FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
